1. Home
  2. BCH vs ASND Comparison

BCH vs ASND Comparison

Compare BCH & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCH

Banco De Chile ADS

HOLD

Current Price

$38.28

Market Cap

15.0B

Sector

Finance

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$213.06

Market Cap

12.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCH
ASND
Founded
1893
2006
Country
Chile
Denmark
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
12.2B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
BCH
ASND
Price
$38.28
$213.06
Analyst Decision
Hold
Strong Buy
Analyst Count
2
15
Target Price
$28.00
$256.40
AVG Volume (30 Days)
263.3K
726.7K
Earning Date
01-30-2026
11-12-2025
Dividend Yield
4.04%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$2,793,481,720.00
$758,592,045.00
Revenue This Year
$17.92
$99.74
Revenue Next Year
$6.34
$79.40
P/E Ratio
$15.21
N/A
Revenue Growth
N/A
97.46
52 Week Low
$22.06
$118.03
52 Week High
$39.19
$229.94

Technical Indicators

Market Signals
Indicator
BCH
ASND
Relative Strength Index (RSI) 61.36 55.20
Support Level $36.80 $192.28
Resistance Level $39.19 $229.94
Average True Range (ATR) 0.64 10.44
MACD -0.08 0.75
Stochastic Oscillator 62.99 57.22

Price Performance

Historical Comparison
BCH
ASND

About BCH Banco De Chile ADS

Operating under three separate brand names (Banco de Chile, Banco Edwards-Citi, and Banco CrediChile), Banco de Chile is the second largest in the country by loans and third largest by deposits. Banco de Chile generates most of its net interest income (roughly 60% of total revenue) from its mortgage, unsecured consumer credit lines, and commercial loans, with 25% of its outstanding loans being made to firms with more than 10,000 million CLP in revenue. Outside of its banking business, Banco de Chile is the largest asset manager in the country and one of the largest security brokerages, supporting its substantial fee-based revenue.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Share on Social Networks: